Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cytokine. 2011 Dec 17;58(1):118–128. doi: 10.1016/j.cyto.2011.11.021

Table 1.

Summary of vaginal cytokines and chemokines evaluated during vaginal candidiasis

Cytokine Reported outcome in
VVC/RVVC
References
Humans Mice Rats
Th1 IL-2 P− P+ P+ [37, 43, 44, 52, 114]
IL-12 P− P− P+ [34, 37, 52, 114]
IFN-γ P−, S+ P− P+ [34, 37, 51, 52]
Th2 IL-4 P−, S+ S+ P− [34, 37, 42, 43, 51, 115]
IL-5 P− P− [37, 115]
IL-13 S+ [115]
Th17 IL-23 P− P− [14, 58](Fidel, submitted)
IL-17 P+/− P+/− [13, 58](Fidel, submitted)
IL-22 P− (Fidel, submitted)
Proinflammatory IL-1α P− [34]
IL-6 P− P+ [13, 34, 44, 114]
G-CSF P− P− [13](Fidel, unpublished data)
TNF-α P− P+ [34, 114]
Regulatory TGF-β I+ I+ [29, 34, 35, 43]
IL-10 P− P−, S+ P+ [29, 34, 43, 44, 114]
Chemokines MCP-1 P− [29, 30]
RANTES P− [30]
IL-8/MIP-2 P−, S+ P− [30, 51, 71]
MIP-1α P− [30]

P, protection; S, susceptibility; I, immunoregulation; +, reported role; −, reported lack of a role